← Leaderboards

Dorothy L Patton

University Of Washington

Google Scholar ↗PubMed ↗ORCID ↗

$29,988,859

Attributed

$31,019,111

Total exposure

67

Grants

42

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY2005–24

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$31,019,111 · 67

By mechanism

P51$13,713,766 · 55

U19$6,731,636 · 4

N01$4,494,984 · 2

R01$3,724,859 · 3

R33$1,424,176 · 1

R21$640,652 · 1

Top collaborators

Lucia N Vojtech2 shared

Most similar at University Of Washington

Same institution · by research overlap

Grace C John-Stewart$42,921,726
Janet S Lee$14,899,810
Anna Wald$34,443,936
Ferric C Fang$28,333,027
Heidi M. Crane$25,961,202

Others in their field

Top investigators on “Sexually Transmitted Diseases”

Wafaa M. El-Sadr · Columbia University Health Sciences$122,097,913
Sten H Vermund · University Of Alabama At Birmingham$117,633,913
Myron S Cohen · Family Health International$108,412,263
Barton F Haynes · Duke University$107,675,530
Taha E Taha · Johns Hopkins University$89,821,106
Willard Cates · Family Health International$66,963,584

Research focus

Sexually Transmitted DiseasesMacacaSafetyVaginaPreventFundingUnited States National Institutes Of HealthMicrobicidePrimatesSourceResourcesGrantEvaluationClinical ResearchMacaca NemestrinaEnvironmentInfectionInstitutionComputer Retrieval Of Information On Scientific Projects DatabasePreventionResearch PersonnelTransmission ProcessChlamydia TrachomatisLocal Microbicides

Grant awards (97)

Coordinated studies in monkeys and humans to assess the immunological impact of rectal Chlamydia trachomatis infection on protection against genital infection$1,127,093

R01 · FY2024 · AI · contact PI

Coordinated studies in monkeys and humans to assess the immunological impact of rectal Chlamydia trachomatis infection on protection against genital infection$933,412

R01 · FY2023 · AI · contact PI

Core B - Nonhuman Primate Studies$536,434

U19 · FY2019 · AI · contact PI

Core B - Nonhuman Primate Studies$335,097

U19 · FY2018 · AI · contact PI

Core B - Nonhuman Primate Studies$344,752

U19 · FY2017 · AI · contact PI

Core B - Nonhuman Primate Studies$355,000

U19 · FY2016 · AI · contact PI

Core B - Nonhuman Primate Studies$445,300

U19 · FY2015 · AI · contact PI

Nonhuman Primate Studies of Tenofovir and UC781$438,472

U19 · FY2014 · AI · contact PI

Nonhuman Primate Studies of Tenofovir and UC781$505,452

U19 · FY2013 · AI · contact PI

Nonhuman Primate Studies of Tenofovir and UC781$456,130

U19 · FY2012 · AI · contact PI

Nonhuman Primate Studies of Tenofovir and UC781$515,501

U19 · FY2011 · AI · contact PI

Improved Macaque Safety Model for Topical Microbicides: Post-coital Assessments$490,354

R33 · FY2011 · AI · contact PI

PROJECT 2 TENOFOVIR$377,899

P51 · FY2011 · RR · contact PI

CHLAMYDIA VACCINE STUDIES IN THE PIGTAIL MACAQUE$377,899

P51 · FY2011 · RR · contact PI

TOPICAL MICROBICIDE SAFETY AND EFFICACY EVALUATION$377,899

P51 · FY2011 · RR · contact PI

IMPROVED MACAQUE SAFETY MODEL FOR TOPICAL MICROBICIDES: POST-COITAL ASSESSMENTS$246,408

P51 · FY2011 · RR · contact PI

Improved Macaque Safety Model for Topical Microbicides: Post-coital Assessments$470,320

R33 · FY2010 · AI · contact PI

IMPROVED MACAQUE SAFETY MODEL FOR TOPICAL MICROBICIDES: POST-COITAL ASSESSMENTS$465,257

P51 · FY2010 · RR · contact PI

TOPICAL MICROBICIDE SAFETY AND EFFICACY EVALUATION$465,257

P51 · FY2010 · RR · contact PI

LB/CV-N AND RC101 PRIMATE TESTING$465,257

P51 · FY2010 · RR · contact PI

Nonhuman Primate Studies of Tenofovir and UC781$378,179

U19 · FY2010 · AI · contact PI

LACTOBACILLI SAFETY STUDIES$310,172

P51 · FY2010 · RR · contact PI

CHLAMYDIA VACCINE STUDIES IN THE PIGTAIL MACAQUE$155,089

P51 · FY2010 · RR · contact PI

Topical Microbicide Safety and Efficacy Evaluation in Nonhuman Primates$1,697,440

N01 · FY2009 · AI · contact PI

STD PREVENTION-PRIMATE UNIT$497,090

P51 · FY2009 · RR · contact PI

Improved Macaque Safety Model for Topical Microbicides: Post-coital Assessments$463,502

R33 · FY2009 · AI · contact PI

LB/CV-N AND RC101 PRIMATE TESTING$331,393

P51 · FY2009 · RR · contact PI

LACTOBACILLI SAFETY STUDIES$331,393

P51 · FY2009 · RR · contact PI

ANIMAL MODELS FOR COMBINATION MICROBICIDES$331,393

P51 · FY2009 · RR · contact PI

TOPICAL MICROBICIDE SAFETY AND EFFICACY EVALUATION$331,393

P51 · FY2009 · RR · contact PI

IMPROVED MACAQUE SAFETY MODEL FOR TOPICAL MICROBICIDES: POST-COITAL ASSESSMENTS$331,393

P51 · FY2009 · RR · contact PI

ANIMAL MODELS FOR COMBINATION MICROBICIDES$422,135

P51 · FY2008 · RR · contact PI

LACTOBACILLI SAFETY STUDIES$422,135

P51 · FY2008 · RR · contact PI

STD PREVENTION-PRIMATE UNIT$422,135

P51 · FY2008 · RR · contact PI

LB/CV-N AND RC101 PRIMATE TESTING$422,135

P51 · FY2008 · RR · contact PI

IMPROVED MACAQUE SAFETY MODEL FOR TOPICAL MICROBICIDES: POST-COITAL ASSESSMENTS$371,459

P51 · FY2008 · RR · contact PI

TOPICAL MICROBICIDE SAFETY AND EFFICACY EVALUATION$371,459

P51 · FY2008 · RR · contact PI

Improved Macaque Safety Model for Topical Microbicides: Post-coital Assessments$269,419

R21 · FY2008 · AI · contact PI

LAB/CV-N AND RC101 PRIMATE TESTING$257,908

U19 · FY2008 · AI · contact PI

Core--Dendrimer Combo - Macaque Safety Studies$252,999

U19 · FY2008 · AI · contact PI

TOPOICAL MICROBICIDE SAFETY AND EFFICACY IN NONHUMAN PRIMATES$1,779,818

N01 · FY2007 · AI · contact PI

Core--Dendrimer Combo - Macaque Safety Studies$630,788

U19 · FY2007 · AI · contact PI

LB/CV-N AND RC101 PRIMATE TESTING$434,134

P51 · FY2007 · RR · contact PI

LACTOBACILLI SAFETY STUDIES$434,134

P51 · FY2007 · RR · contact PI

STD PREVENTION-PRIMATE UNIT$434,134

P51 · FY2007 · RR · contact PI

Improved Macaque Safety Model for Topical Microbicides: Post-coital Assessments$371,233

R21 · FY2007 · AI · contact PI

LAB/CV-N AND RC101 PRIMATE TESTING$232,947

U19 · FY2007 · AI · contact PI

ANIMAL MODELS FOR COMBINATION MICROBICIDES$208,386

P51 · FY2007 · RR · contact PI

DENDRIMER COMBO: SAFETY$208,385

P51 · FY2007 · RR · contact PI

LAB/CV-N AND RC101 PRIMATE TESTING$252,215

U19 · FY2006 · AI · contact PI

STD PREVENTION-PRIMATE UNIT$228,467

P51 · FY2006 · RR · contact PI

LB/CV-N AND RC101 PRIMATE TESTING$228,467

P51 · FY2006 · RR · contact PI

LACTOBACILLI SAFETY STUDIES$228,467

P51 · FY2006 · RR · contact PI

CHLAMYDIA TRACHOMATIS + SHIV: CO-INFECTION MODEL DEVELOPMENT$228,467

P51 · FY2006 · RR · contact PI

TOPICAL MICROBICIDES FOR PREVENTION OF STDS/HIV INFECTION$228,467

P51 · FY2006 · RR · contact PI

Core--Dendrimer Combo - Macaque Safety Studies$203,371

U19 · FY2006 · AI · contact PI

LOCAL IMMUNE RESPONSE IN CHLAMYDIAL SALPINGITIS$94,326

P51 · FY2006 · RR · contact PI

DENDRIMER COMBO: SAFETY$94,326

P51 · FY2006 · RR · contact PI

ANIMAL MODELS FOR COMBINATION MICROBICIDES$94,326

P51 · FY2006 · RR · contact PI

STD PREVENTION - PRIMATE UNIT$249,042

P51 · FY2005 · RR

Core--Dendrimer Combo - Macaque Safety Studies$215,475

U19 · FY2005 · AI

ANIMAL MODELS FOR COMBINATION MICROBICIDES$175,831

P51 · FY2005 · RR

TOPICAL MICROBICIDES FOR PREVENTION OF STDS/HIV INFECTION$175,831

P51 · FY2005 · RR

LAB/CV-N AND RC101 PRIMATE TESTING$143,727

U19 · FY2005 · AI

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$80,468

P51 · FY2005 · RR

Core--Dendrimer Combo - Macaque Safety Studies$231,889

U19 · FY2004 · AI

STD PREVENTION - PRIMATE UNIT$161,398

P51 · FY2004 · RR

PRIMATE MODEL FOR RECTAL &VAGINAL TOPICAL MICROBICIDE$161,398

P51 · FY2004 · RR

CHLAMYDIA TRACHOMATIS + SHIV: CO-INFECTION MODEL DEVELOPMENT$161,398

P51 · FY2004 · RR

TOPICAL MICROBICIDE FOR PREVENTION OF STDS/HIV INFECTION$161,398

P51 · FY2004 · RR

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$111,746

P51 · FY2004 · RR

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$331,887

R01 · FY2003 · AI

STD PREVENTION - PRIMATE UNIT$189,414

P51 · FY2003 · RR

ANIMAL MODELS FOR COMBINATION MICROBICIDES$189,414

P51 · FY2003 · RR

CHLAMYDIA TRACHOMATIS + SHIV: CO-INFECTION MODEL DEV. IN THE PIG-TAIL MACAQUE$189,414

P51 · FY2003 · RR

TOPICAL MICROBICIDES FOR PREVENTION OF STDS &HIV INFECTION$189,414

P51 · FY2003 · RR

LOCAL IMMUNE RESPONSE IN CHLAMYDIAL SALPINGITIS$90,834

P51 · FY2003 · RR

IMMUNOPATHOGENESIS OF EXPERIMENTAL CHLAMYDIAL SALPINGITIS$90,834

P51 · FY2003 · RR

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$349,307

R01 · FY2002 · AI

BIOLOGICAL MODEL OF SAFETY AND EFFICACY OF TOPICAL MICROBICIDE$230,705

P01 · FY2002 · AI

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$343,810

R01 · FY2001 · AI

GENERIC MICROBICIDES$0

P51 · FY2001 · RR

MIC 90 TROVAFLOXACIN$0

P51 · FY2001 · RR

MIC 90 TROVAFLOXACIN$0

P51 · FY2001 · RR

TOPICAL MICROBICIDES FOR PREVENTION OF STD &HIV INFECTION$0

P51 · FY2001 · RR

EXPERIMENTAL MACAQUE PELVIC INFLAMMATORY DISEASE$0

P51 · FY2001 · RR

BIOLOGICAL MODEL OF SAFETY AND EFFICACY OF TOPICAL MICROBICIDE$0

P01 · FY2001 · AI

STDS PREVENTION - PRIMATE UNIT$1,017,726

N01 · FY2000 · AI

LOCAL IMMUNE RESPONSE IN CHLAMYDIA SALPINGITIS$331,135

R01 · FY2000 · AI

IMMUNOPATHOGENESIS--EXPERIMENTAL CHLAMYDIAL SALPINGITIS$308,215

R01 · FY2000 · AI

TOPICAL MICROBICIDES FOR PREVENTION OF STDS &HIV INFECTION$132,406

P51 · FY2000 · RR

MIC 90 TROVAFLOXACIN$74,623

P51 · FY2000 · RR

BIOLOGICAL MODEL OF SAFETY AND EFFICACY OF TOPICAL MICROBICIDE$58,333

P01 · FY2000 · AI

GENERIC MICROBICIDES$52,589

P51 · FY2000 · RR

IMMUNOPATHOGENESIS OF EXPERIMENTAL CHLAMYDIAL SALPINGITIS$52,589

P51 · FY2000 · RR

LOCAL IMMUNE RESPONSE IN CHLAMYDIAL SALPINGITIS$52,589

P51 · FY2000 · RR

STDS PREVENTION - PRIMATE UNIT$0

N01 · FY2000 · AI